No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
OMCL Omnicell
- 27.910
- +0.680+2.50%
Close Jun 14 16:00 ET
- 27.770
- -0.140-0.50%
Post 16:40 ET
1.28BMarket Cap-60673P/E (TTM)
28.060High26.490Low515.93KVolume26.930Open27.230Pre Close14.23MTurnover1.20%Turnover RatioLossP/E (Static)45.92MShares75.07052wk High1.08P/B1.20BFloat Cap25.69052wk Low--Dividend TTM42.87MShs Float187.285Historical High--Div YieldTTM5.77%Amplitude1.290Historical Low27.572Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Is Omnicell (NASDAQ:OMCL) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Here's Why Omnicell (OMCL) Should Be in Your Portfolio Now
Wells Fargo Maintains Omnicell(OMCL.US) With Hold Rating, Maintains Target Price $26
Wells Fargo analyst Stan Berenshteyn maintains $Omnicell(OMCL.US)$ with a hold rating, and maintains the target price at $26.According to TipRanks data, the analyst has a success rate of 55.8% and a t
Omnicell (OMCL) Gains From New Offerings Amid Cost Woes
Estimating The Intrinsic Value Of Omnicell, Inc. (NASDAQ:OMCL)
Investors Aren't Buying Omnicell, Inc.'s (NASDAQ:OMCL) Revenues
With a price-to-sales (or "P/S") ratio of 1.3x Omnicell, Inc. (NASDAQ:OMCL) may be sending bullish signals at the moment, given that almost half of all the Medical Equipment companies in the United St
Comments
Omnicell stock is undervalued, presenting a buying opportunity. The company's future outlook is optimistic with robust cash flows expected to increase share value. However, consider other factors like financial health before investing.
Is Now The Time To Look At Buying Omnicell, Inc. (NASDAQ:OMCL)?The company's debt situation and EBIT loss of US$31m over the last twelve months raise concerns about its financial health. The balance sheet is considered far from match-fit and the stock is deemed very risky.
Omnicell's low P/S ratio suggests limited growth. Lackluster future revenue forecasts damages its value. Investors await improved performance as current weak outlook pressures stock price.
Given the falling EPS and poor performance over the last three years, future earnings performance is being considered critical for shareholders. Potential investors are cautioned to ensure they are investing in a high-quality business amid challenges.
The sharp cut to revenue forecasts suggests that investors should temper their expectations for Omnicell, Inc. Also, analysts anticipate slower revenue growth than the wider market, which could lead to increased caution among investors.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
